{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:39Z","timestamp":1791928959831,"version":"4.3.4"},"reference-count":136,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.1167\/iovs.67.2.31","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:30:43Z","timestamp":1770906643000},"page":"31","source":"Crossref","is-referenced-by-count":1,"title":["Morpho-Functional Characterization and miRNA Profiling of the Retina in the 5xFAD Murine Model of Alzheimer's Disease"],"prefix":"10.1167","volume":"67","author":[{"given":"Lorenzo","family":"Guidotti","sequence":"first","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lucchesi","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Daghini","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Amato","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Neri","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Corsi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marracci","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gargini","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Borello","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cammalleri","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dal Monte","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Casini","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"1","key":"bib1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-024-00434-9","article-title":"Trajectory of brain-derived amyloid beta in Alzheimer's disease: where is it coming from and where is it going?","volume":"13","author":"Liu","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"3","key":"bib2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jnc.15565","article-title":"Reactive astrogliosis: a friend or foe in the pathogenesis of Alzheimer's disease","volume":"164","author":"Kumar","year":"2023","journal-title":"J Neurochem"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"04","DOI":"10.3389\/fnagi.2018.00004","article-title":"Autophagy and Alzheimer's disease: from molecular mechanisms to therapeutic implications","volume":"10","author":"Uddin","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","article-title":"Molecular mechanisms linking amyloid \u00df toxicity and Tau hyperphosphorylation in Alzheimer?s disease","volume":"83","author":"Lloret","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"bib5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"8","key":"bib6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","article-title":"A clinicopathological approach to the diagnosis of dementia","volume":"13","author":"Elahi","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"bib7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaneurol.2015.3098","article-title":"Association of elevated amyloid levels with cognition and biomarkers in cognitively normal people from the community","volume":"73","author":"Petersen","year":"2016","journal-title":"JAMA Neurol"},{"issue":"6","key":"bib8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/ana.24040","article-title":"Predicting Alzheimer disease with \u00df-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing","volume":"74","author":"Rowe","year":"2013","journal-title":"Ann Neurol"},{"issue":"11","key":"bib9","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.1016\/S2589-7500(22)00169-8","article-title":"A deep learning model for detection of Alzheimer's disease based on retinal photographs: a retrospective, multicentre case-control study","volume":"4","author":"Cheung","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"1","key":"bib10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/alz.12006","article-title":"Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward","volume":"16","author":"Alber","year":"2020","journal-title":"Alzheimers Dement"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fnins.2020.00921","article-title":"Alzheimer's retinopathy: seeing disease in the eyes","volume":"14","author":"Mirzaei","year":"2020","journal-title":"Front Neurosci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pharmthera.2017.02.009","article-title":"Retinal biomarkers provide \u201cinsight\u201d into cortical pharmacology and disease","volume":"175","author":"Nguyen","year":"2017","journal-title":"Pharmacol Ther"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fnins.2016.00536","article-title":"The eye as a biomarker for Alzheimer's disease","volume":"10","author":"Lim","year":"2016","journal-title":"Front Neurosci"},{"issue":"1","key":"bib14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/156720510790274491","article-title":"Alzheimer's disease and retinal neurodegeneration","volume":"7","author":"Guo","year":"2010","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"bib15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain-from eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"bib16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/stem.602","article-title":"Concise review: making a retina\u2013from the building blocks to clinical applications","volume":"29","author":"Wallace","year":"2011","journal-title":"Stem Cells"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpmo.39","article-title":"Noninvasive electroretinographic procedures for the study of the mouse retina","volume":"8","author":"Kinoshita","year":"2018","journal-title":"Curr Protoc Mouse Biol"},{"key":"bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/B978-0-444-64032-1.00032-1","article-title":"Electroretinograms","volume":"160","author":"Creel","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2015.05.008","article-title":"Electrophysiological assessment of retinal ganglion cell function","volume":"141","author":"Porciatti","year":"2015","journal-title":"Exp Eye Res"},{"issue":"5","key":"bib20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jnen\/nlx020","article-title":"Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease","volume":"76","author":"Williams","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"bib21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bpa.12070","article-title":"Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients","volume":"24","author":"Ho","year":"2014","journal-title":"Brain Pathol"},{"issue":"12","key":"bib22","doi-asserted-by":"publisher","first-page":"e53547","DOI":"10.1371\/journal.pone.0053547","article-title":"Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice","volume":"7","author":"Sch\u00f6n","year":"2012","journal-title":"PLoS One"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fnins.2019.00925","article-title":"Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimer's disease patients, possible biomarkers for early diagnosis","volume":"13","author":"Grimaldi","year":"2019","journal-title":"Front Neurosci"},{"issue":"16","key":"bib24","doi-asserted-by":"publisher","first-page":"e93621","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease","volume":"17","author":"Koronyo","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"bib25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","article-title":"Melanopsin retinal ganglion cell loss in Alzheimer disease","volume":"79","author":"La Morgia","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"bib26","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"issue":"3","key":"bib27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0197-4580(96)00010-3","article-title":"Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal\/parafoveal retina","volume":"17","author":"Blanks","year":"1996","journal-title":"Neurobiol Aging"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fneur.2016.00055","article-title":"Visual and ocular manifestations of Alzheimer's disease and their use as biomarkers for diagnosis and progression","volume":"7","author":"Javaid","year":"2016","journal-title":"Front Neurol"},{"issue":"10","key":"bib29","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/01.wnl.0000244490.07925.8b","article-title":"Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging","volume":"67","author":"Danesh-Meyer","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"bib30","first-page":"1","article-title":"A quantitative analysis of optic nerve axons in elderly control subjects and patients with Alzheimer's disease","volume":"43","author":"Syed","year":"2005","journal-title":"Folia Neuropathol"},{"issue":"8","key":"bib31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198608213150804","article-title":"Optic-nerve degeneration in Alzheimer's disease","volume":"315","author":"Hinton","year":"1986","journal-title":"N Engl J Med"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","article-title":"Retinal thickness in Alzheimer's disease: a systematic review and meta-analysis","volume":"6","author":"den Haan","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"bib33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.dadm.2015.03.001","article-title":"A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography","volume":"1","author":"Thomson","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"issue":"5","key":"bib34","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","article-title":"Retinal abnormalities in early Alzheimer's disease","volume":"48","author":"Berisha","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2007.02.090","article-title":"Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease","volume":"420","author":"Paquet","year":"2007","journal-title":"Neurosci Lett"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","article-title":"Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease","volume":"26","author":"Iseri","year":"2006","journal-title":"J Neuroophthalmol"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.dadm.2016.09.001","article-title":"Nonvascular retinal imaging markers of preclinical Alzheimer's disease","volume":"4","author":"Snyder","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"bib38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10633-010-9238-x","article-title":"Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease","volume":"121","author":"Krasodomska","year":"2010","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"bib39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ygyno.2021.09.015","article-title":"MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma","volume":"163","author":"Lee","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"bib40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13024-021-00496-7","article-title":"The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives","volume":"16","author":"Walgrave","year":"2021","journal-title":"Mol Neurodegener"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.omtn.2020.01.010","article-title":"miRNA-31 improves cognition and abolishes amyloid-\u00df pathology by targeting APP and BACE1 in an animal model of Alzheimer's disease","volume":"19","author":"Barros-Viegas","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"bib42","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3892\/mmr.2014.2484","article-title":"MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease","volume":"10","author":"Liu","year":"2014","journal-title":"Mol Med Rep"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2011.10.051","article-title":"MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2","volume":"1455","author":"Liang","year":"2012","journal-title":"Brain Res"},{"issue":"37","key":"bib44","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","article-title":"MicroRNA-153 physiologically inhibits expression of amyloid-\u00df precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients","volume":"287","author":"Long","year":"2012","journal-title":"J Biol Chem"},{"issue":"24","key":"bib45","doi-asserted-by":"publisher","first-page":"18344","DOI":"10.1074\/jbc.M110.112664","article-title":"MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons","volume":"285","author":"Vilardo","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"bib46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","article-title":"MicroRNA regulation of Alzheimer's Amyloid precursor protein expression","volume":"33","author":"H\u00e9bert","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"10","key":"bib47","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/s41380-019-0610-2","article-title":"MicroRNA-298 reduces levels of human amyloid-\u00df precursor protein (APP), \u00df-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties","volume":"26","author":"Chopra","year":"2021","journal-title":"Mol Psychiatry"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting amyloidogenic processing of APP in Alzheimer's disease","volume":"13","author":"Zhao","year":"2020","journal-title":"Front Mol Neurosci"},{"issue":"69","key":"bib49","doi-asserted-by":"publisher","first-page":"114065","DOI":"10.18632\/oncotarget.23119","article-title":"MiR-124 acts as a target for Alzheimer's disease by regulating BACE1","volume":"8","author":"An","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"bib50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3892\/ijmm.2014.1780","article-title":"MicroRNA-384 regulates both amyloid precursor protein and \u00df-secretase expression and is a potential biomarker for Alzheimer's disease","volume":"34","author":"Liu","year":"2014","journal-title":"Int J Mol Med"},{"issue":"44","key":"bib51","doi-asserted-by":"publisher","first-page":"14717","DOI":"10.1523\/JNEUROSCI.2053-15.2015","article-title":"microRNA-33 regulates ApoE lipidation and amyloid-\u00df metabolism in the brain","volume":"35","author":"Kim","year":"2015","journal-title":"J Neurosci"},{"issue":"4","key":"bib52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-018-1880-5","article-title":"MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways","volume":"136","author":"El Fatimy","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"9","key":"bib53","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.15252\/emmm.201606520","article-title":"Vanden Eynden E, De Strooper B. miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain","volume":"8","author":"Salta","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"23","key":"bib54","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","article-title":"miR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo","volume":"24","author":"Smith","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"37","key":"bib55","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","article-title":"MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons","volume":"33","author":"Absalon","year":"2013","journal-title":"J Neurosci"},{"issue":"6","key":"bib56","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/jnc.12437","article-title":"Alternative polyadenylation and miR-34 family members regulate tau expression","volume":"127","author":"Dickson","year":"2013","journal-title":"J Neurochem"},{"issue":"23-24","key":"bib57","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1101\/gad.348874.121","article-title":"Widespread microRNA degradation elements in target mRNAs can assist the encoded proteins","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev"},{"issue":"12","key":"bib58","doi-asserted-by":"publisher","first-page":"8376","DOI":"10.1007\/s12035-019-01676-9","article-title":"A systematic review of microRNA expression as biomarker of late-onset Alzheimer's disease","volume":"56","author":"Herrera-Espejo","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"5","key":"bib59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/1354750X.2013.814073","article-title":"MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma","volume":"18","author":"Bekris","year":"2013","journal-title":"Biomarkers"},{"issue":"7","key":"bib60","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","article-title":"A blood based 12-miRNA signature of Alzheimer disease patients","volume":"14","author":"Leidinger","year":"2013","journal-title":"Genome Biol"},{"issue":"1","key":"bib61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"bib62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci Data"},{"issue":"40","key":"bib63","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"713726","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s42003-019-0599-8","article-title":"3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice","volume":"2","author":"Gail Canter","year":"2019","journal-title":"Commun Biol"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-8-2","article-title":"Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal A\u00df42 accumulation and Caspase-3 activation","volume":"8","author":"Eimer","year":"2013","journal-title":"Mol Neurodegener"},{"issue":"1","key":"bib67","doi-asserted-by":"publisher","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u00df aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"2","key":"bib68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","article-title":"Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model","volume":"33","author":"Kimura","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"3","key":"bib69","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc Ophthalmol"},{"issue":"16","key":"bib70","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0042-6989(00)00081-X","article-title":"Behavioral assessment of visual acuity in mice and rats","volume":"40","author":"Prusky","year":"2000","journal-title":"Vision Res"},{"issue":"3","key":"bib71","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.apjo.2025.100192","article-title":"The efficacy of Saffron Repron in counteracting the progression of retinitis pigmentosa: neuroprotection and resilience","volume":"14","author":"Corsi","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"bib72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet.journal"},{"issue":"D1","key":"bib73","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"bib74","doi-asserted-by":"publisher","first-page":"e1000386","DOI":"10.1371\/journal.pcbi.1000386","article-title":"SHRiMP: accurate mapping of short color-space reads","volume":"5","author":"Rumble","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"bib75","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"17","key":"bib76","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","article-title":"The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations","volume":"42","author":"Ru","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"bib77","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"1","key":"bib78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10633-017-9595-9","article-title":"Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography","volume":"135","author":"Cvenkel","year":"2017","journal-title":"Doc Ophthalmol"},{"issue":"6","key":"bib79","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1167\/iovs.05-1461","article-title":"Study of rod- and cone-driven oscillatory potentials in mice","volume":"47","author":"Lei","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"bib80","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1017\/S0952523804214043","article-title":"Origins of the electroretinogram oscillatory potentials in the rabbit retina","volume":"21","author":"Dong","year":"2004","journal-title":"Vis Neurosci"},{"issue":"3","key":"bib81","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1167\/iovs.03-1080","article-title":"Oscillatory potential analysis and ERGs of normal and diabetic rats","volume":"45","author":"Hancock","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib82","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.3390\/ijms25126766","article-title":"Behaviour hallmarks in Alzheimer's disease 5xFAD mouse model","volume":"25","author":"P\u00e1dua","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"bib83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40035-023-00386-6","article-title":"N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer's disease","volume":"12","author":"Wang","year":"2023","journal-title":"Transl Neurodegener"},{"issue":"1","key":"bib84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13195-025-01784-w","article-title":"A longitudinal study of the 5xFAD mouse retina delineates amyloid beta (A\u00df)-mediated retinal pathology from age-related changes","volume":"17","author":"Lynn","year":"2025","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"bib85","doi-asserted-by":"publisher","first-page":"e0319397","DOI":"10.1371\/journal.pone.0319397","article-title":"Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease","volume":"20","author":"McCool","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"bib86","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1038\/s41598-021-84318-2","article-title":"Rod pathway and cone pathway retinal dysfunction in the 5xFAD mouse model of Alzheimer's disease","volume":"11","author":"McAnany","year":"2021","journal-title":"Sci Rep"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"681831","DOI":"10.3389\/fnins.2021.681831","article-title":"Brain and retinal abnormalities in the 5xFAD mouse model of Alzheimer's disease at early stages","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","article-title":"Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer's disease","volume":"14","author":"Lim","year":"2020","journal-title":"Front Neurosci"},{"issue":"11","key":"bib89","doi-asserted-by":"publisher","first-page":"103327","DOI":"10.1016\/j.isci.2021.103327","article-title":"Identification of early-onset photoreceptor degeneration in transgenic mouse models of Alzheimer's disease","volume":"24","author":"Zhang","year":"2021","journal-title":"iScience"},{"issue":"23","key":"bib90","doi-asserted-by":"publisher","first-page":"9397","DOI":"10.1073\/pnas.0808940106","article-title":"Depleting Rac1 in mouse rod photoreceptors protects them from photo-oxidative stress without affecting their structure or function","volume":"106","author":"Haruta","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib91","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2015.05.008","article-title":"Electrophysiological assessment of retinal ganglion cell function","volume":"141","author":"Porciatti","year":"2015","journal-title":"Exp Eye Res"},{"issue":"s1","key":"bib92","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3233\/JAD-201195","article-title":"Retinal ganglion cells functional changes in a mouse model of Alzheimer's disease are linked with neurotransmitter alterations","volume":"82","author":"Araya-Arriagada","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"bib93","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","article-title":"Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer's disease","volume":"14","author":"Lim","year":"2020","journal-title":"Front Neurosci"},{"issue":"15","key":"bib94","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/cells11152413","article-title":"Retinal vascular physiology biomarkers in a 5XFAD mouse model of Alzheimer's disease","volume":"11","author":"Matei","year":"2022","journal-title":"Cells"},{"key":"bib95","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","article-title":"Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer's disease","volume":"14","author":"Lim","year":"2020","journal-title":"Front Neurosci"},{"key":"bib96","doi-asserted-by":"publisher","first-page":"1434551","DOI":"10.3389\/fnagi.2024.1434551","article-title":"Abnormal outer and inner retina in a mouse model of Huntington's disease with age","volume":"16","author":"Yang","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"bib97","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fneur.2017.00710","article-title":"Patterns of retinal ganglion cell damage in neurodegenerative disorders: parvocellular vs magnocellular degeneration in optical coherence tomography studies","volume":"8","author":"La Morgia","year":"2017","journal-title":"Front Neurol"},{"issue":"1","key":"bib98","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40478-016-0346-z","article-title":"The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain","volume":"4","author":"Normando","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"s1","key":"bib99","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u00df oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"bib100","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology, and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"bib101","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/jnc.12202","article-title":"Alzheimer's A\u00df42 and A\u00df40 peptides form interlaced amyloid fibrils","volume":"126","author":"Gu","year":"2013","journal-title":"J Neurochem"},{"key":"bib102","doi-asserted-by":"publisher","first-page":"937133","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer's disease: an insight","volume":"15","author":"Goel","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"bib103","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1523\/JNEUROSCI.4736-04.2005","article-title":"Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w","volume":"25","author":"Yao","year":"2005","journal-title":"J Neurosci"},{"key":"bib104","doi-asserted-by":"publisher","first-page":"681831","DOI":"10.3389\/fnins.2021.681831","article-title":"Brain and retinal abnormalities in the 5xFAD mouse model of Alzheimer's disease at early stages","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci"},{"issue":"5","key":"bib105","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2353\/ajpath.2009.090159","article-title":"Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice","volume":"175","author":"Liu","year":"2009","journal-title":"Am J Pathol"},{"issue":"2","key":"bib106","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1167\/iovs.08-2384","article-title":"Beta-amyloid deposition and functional impairment in the retina of the APPswe\/PS1DeltaE9 transgenic mouse model of Alzheimer's disease","volume":"50","author":"Perez","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"bib107","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1167\/iovs.08-1849","article-title":"Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease","volume":"49","author":"Ning","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"bib108","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/biom14070833","article-title":"Targeting microglia in Alzheimer's disease: pathogenesis and potential therapeutic strategies","volume":"14","author":"Sun","year":"2024","journal-title":"Biomolecules"},{"issue":"33","key":"bib109","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"bib110","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1038\/s41467-024-54779-w","article-title":"Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer's Disease","volume":"15","author":"Balig\u00e1cs","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"bib111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41593-021-00963-w","article-title":"Two-faced behavior of microglia in Alzheimer's disease","volume":"25","author":"Chen","year":"2022","journal-title":"Nat Neurosci"},{"key":"bib112","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer's disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"bib113","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.7150\/ijbs.81900","article-title":"\u00df-amyloid binds to microglia Dectin-1 to induce inflammatory response in the pathogenesis of Alzheimer's disease","volume":"19","author":"Zhao","year":"2023","journal-title":"Int J Biol Sci"},{"key":"bib114","doi-asserted-by":"publisher","first-page":"102578","DOI":"10.1016\/j.arr.2024.102578","article-title":"Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer's disease: a narrative review","volume":"102","author":"Maggiore","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"6","key":"bib115","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/glia.24514","article-title":"ER-stress response in retinal M\u00fcller glia occurs significantly earlier than amyloid pathology in the Alzheimer's mouse brain and retina","volume":"72","author":"Palko","year":"2024","journal-title":"Glia"},{"issue":"1","key":"bib116","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","article-title":"M\u00fcller cell degeneration and microglial dysfunction in the Alzheimer's retina","volume":"10","author":"Xu","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"bib117","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3233\/JAD-160823","article-title":"Investigations into retinal pathology in the early stages of a mouse model of Alzheimer's disease","volume":"56","author":"Chidlow","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"bib118","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.exer.2014.08.006","article-title":"Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease","volume":"127","author":"Edwards","year":"2014","journal-title":"Exp Eye Res"},{"issue":"3","key":"bib119","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","article-title":"Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL","volume":"17","author":"Blanks","year":"1996","journal-title":"Neurobiol Aging"},{"key":"bib120","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"bib121","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-025-01935-y","article-title":"Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease","volume":"13","author":"Davis","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"bib122","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J Neuroinflammation"},{"issue":"1","key":"bib123","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-022-02567-y","article-title":"Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer's disease","volume":"19","author":"Dong","year":"2022","journal-title":"J Neuroinflammation"},{"key":"bib124","doi-asserted-by":"publisher","first-page":"1530809","DOI":"10.3389\/fnins.2024.1530809","article-title":"Lastres-Becker I. RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection","volume":"18","author":"Silva-Llanes","year":"2025","journal-title":"Front Neurosci"},{"issue":"1","key":"bib125","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00401-024-02747-5","article-title":"The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease","volume":"147","author":"Balusu","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"1","key":"bib126","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-025-01935-y","article-title":"Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease","volume":"13","author":"Davis","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"bib127","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fgene.2019.00153","article-title":"MicroRNAs in Alzheimer's disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front Genet"},{"key":"bib128","doi-asserted-by":"publisher","first-page":"894938","DOI":"10.4061\/2011\/894938","article-title":"MicroRNAs and Alzheimer's disease mouse models: current insights and future research avenues","volume":"2011","author":"Delay","year":"2011","journal-title":"Int J Alzheimers Dis"},{"issue":"1","key":"bib129","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","article-title":"MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy","volume":"14","author":"Li","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"9","key":"bib130","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/leu.2015.101","article-title":"MicroRNA-124 links p53 to the NF-?B pathway in B-cell lymphomas","volume":"29","author":"Jeong","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"bib131","first-page":"2551","article-title":"MicroRNA-124 improves functional recovery and suppresses Bax-dependent apoptosis in rats following spinal cord injury","volume":"19","author":"Xu","year":"2019","journal-title":"Mol Med Rep"},{"issue":"1","key":"bib132","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s12864-024-10679-3","article-title":"Transcriptomic profile of Lin-Sca1+c-kit (LSK) cells in db\/db mice with long-standing diabetes","volume":"25","author":"Mahajan","year":"2024","journal-title":"BMC Genomics"},{"issue":"2","key":"bib133","doi-asserted-by":"publisher","first-page":"e70019","DOI":"10.1002\/alz.70019","article-title":"Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease","volume":"21","author":"Counts","year":"2025","journal-title":"Alzheimers Dement"},{"key":"bib134","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41380-025-02925-1","article-title":"Circular RNAs in neurological conditions \u2013 computational identification, functional validation, and potential clinical applications","volume":"30","author":"Hatzimanolis","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"14","key":"bib135","doi-asserted-by":"publisher","first-page":"e2107534","DOI":"10.1002\/smll.202107534","article-title":"Brain-penetration and neuron-targeting DNA nanoflowers co-delivering miR-124 and rutin for synergistic therapy of Alzheimer's disease","volume":"18","author":"Ouyang","year":"2022","journal-title":"Small"},{"issue":"5","key":"bib136","doi-asserted-by":"publisher","first-page":"e70290","DOI":"10.1002\/jbt.70290","article-title":"Evaluation of the neurotherapeutic effect of quercetin on neuronal miR-124 and \u00df-site amyloid precursor protein cleaving enzyme 1 (BACE1) in an experimental Alzheimer's disease model","volume":"39","author":"Al-Sawasany","year":"2025","journal-title":"J Biochem Mol Toxicol"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.2.31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:17Z","timestamp":1791927137000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.2.31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.2.31","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}